| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018951766 |
| P356 | DOI | 10.1186/AR2486 |
| P932 | PMC publication ID | 2592775 |
| P698 | PubMed publication ID | 18947373 |
| P5875 | ResearchGate publication ID | 23409939 |
| P2093 | author name string | Jacob M van Laar | |
| Thomas Hügle | |||
| P2860 | cites work | Expression and function of c-kit in hemopoietic progenitor cells | Q24675808 |
| Immune ablation and stem-cell therapy in autoimmune disease. Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation | Q24791017 | ||
| A modification of Jerne's theory of antibody production using the concept of clonal selection | Q28252422 | ||
| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 | ||
| Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 | ||
| Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation | Q73919404 | ||
| Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation | Q74324034 | ||
| Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis | Q74357448 | ||
| Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases | Q78536979 | ||
| Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease? | Q79799061 | ||
| Autologous stem cell transplantation for systemic lupus erythematosus | Q80031296 | ||
| Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells | Q80160255 | ||
| Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis | Q80384852 | ||
| Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect | Q80390067 | ||
| Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial | Q80544807 | ||
| Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells | Q80650139 | ||
| Autologous stem cell transplantation improves microcirculation in systemic sclerosis | Q80793801 | ||
| Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation | Q80836510 | ||
| Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus | Q81074763 | ||
| Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease | Q81461498 | ||
| Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation | Q81712990 | ||
| Tolerance induction by bone marrow transplantation in a multiple sclerosis model | Q81756958 | ||
| Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice | Q83880478 | ||
| Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network | Q94462415 | ||
| Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? | Q33314922 | ||
| Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells | Q33865273 | ||
| Stem cell transplantation in experimental models of autoimmune disease | Q33911440 | ||
| Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases | Q34010216 | ||
| Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis | Q34207677 | ||
| Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry | Q35554404 | ||
| Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a r | Q35638755 | ||
| High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study | Q35925071 | ||
| Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease | Q36141721 | ||
| Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions | Q36164087 | ||
| Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment | Q36362491 | ||
| CD4+CD25+ regulatory T cells and graft-versus-host disease. | Q36368127 | ||
| Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. | Q36402704 | ||
| Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans | Q36627829 | ||
| Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis | Q36975539 | ||
| Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice | Q37446632 | ||
| Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus | Q38409483 | ||
| Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs | Q38487883 | ||
| Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). | Q41457500 | ||
| Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation | Q41469436 | ||
| Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches | Q42083509 | ||
| High-dose cyclophosphamide without stem cell rescue in scleroderma. | Q42636042 | ||
| Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. | Q43574445 | ||
| High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus | Q44278522 | ||
| Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. | Q44782750 | ||
| Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism | Q44821872 | ||
| Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. | Q52044336 | ||
| Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. | Q52264457 | ||
| Direct assessment of thymic reactivation after autologous stem cell transplantation. | Q52920124 | ||
| Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis. | Q53538901 | ||
| Allogeneic bone marrow transplantation (BMT) for refractory Behçet's disease with severe CNS involvement. | Q53541418 | ||
| Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment | Q56906119 | ||
| Targeting host B-cell immune responses by persistent donor NK-cell alloreactivity following nonmyeloablative allogeneic stem cell transplantation | Q58234943 | ||
| Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation | Q58234977 | ||
| Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database | Q59389223 | ||
| Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies | Q61873063 | ||
| Autologous hematopoietic stem cell transplantation for autoimmune diseases | Q63214396 | ||
| Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation | Q70884367 | ||
| Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation | Q71910154 | ||
| High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy | Q73792142 | ||
| Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells | Q73821475 | ||
| P433 | issue | 5 | |
| P921 | main subject | rheumatism | Q684924 |
| autoimmune disease | Q8084905 | ||
| P304 | page(s) | 217 | |
| P577 | publication date | 2008-10-10 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Stem cell transplantation for rheumatic autoimmune diseases | |
| P478 | volume | 10 |
| Q85167954 | A Case of Ulcerative Colitis Associated With Autoimmune Hemolytic Anemia Successfully Treated by Autologous Hematopoietic Stem Cell Transplantation |
| Q37719559 | Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus |
| Q38041499 | An update on stem cell transplantation in autoimmune rheumatologic disorders |
| Q37687432 | Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications. |
| Q41875089 | Dexamethasone preconditioning improves the response of collagen-induced arthritis to treatment with short-term lipopolysaccharide-stimulated collagen-loaded dendritic cells. |
| Q58036602 | First autologous hematopoietic SCT for ankylosing spondylitis: a case report and clues to understanding the therapy |
| Q38466458 | Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis |
| Q26751425 | Hematopoietic stem cell transplantation for auto immune rheumatic diseases |
| Q42868832 | Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice |
| Q42640329 | Introducing Arthritis Research & Therapy's 10th anniversary issue, 'The Scientific Basis of Rheumatology: A Decade of Progress'. |
| Q33837175 | Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. |
| Q38794663 | Recent advances and current state of immunotherapy in systemic lupus erythematosus |
| Q38265814 | Stem cell therapies for systemic sclerosis. |
| Q43173646 | Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis |
| Q38091659 | Update on stem cell transplantation for systemic sclerosis: recent trial results |
Search more.